UniProt ID | HS71L_HUMAN | |
---|---|---|
UniProt AC | P34931 | |
Protein Name | Heat shock 70 kDa protein 1-like | |
Gene Name | HSPA1L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 641 | |
Subcellular Localization | ||
Protein Description | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. [PubMed: 26865365 Positive regulator of PRKN translocation to damaged mitochondria] | |
Protein Sequence | MATAKGIAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPQNTVFDAKRLIGRKFNDPVVQADMKLWPFQVINEGGKPKVLVSYKGENKAFYPEEISSMVLTKLKETAEAFLGHPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDKGGQGERHVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVSHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQANLEIDSLYEGIDFYTSITRARFEELCADLFRGTLEPVEKALRDAKMDKAKIHDIVLVGGSTRIPKVQRLLQDYFNGRDLNKSINPDEAVAYGAAVQAAILMGDKSEKVQDLLLLDVAPLSLGLETAGGVMTALIKRNSTIPTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFDLTGIPPAPRGVPQIEVTFDIDANGILNVTATDKSTGKVNKITITNDKGRLSKEEIERMVLDAEKYKAEDEVQREKIAAKNALESYAFNMKSVVSDEGLKGKISESDKNKILDKCNELLSWLEVNQLAEKDEFDHKRKELEQMCNPIITKLYQGGCTGPACGTGYVPGRPATGPTIEEVD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Phosphorylation | AIGIDLGTTYSCVGV EEEEECCCCEEEEEE | 29.83 | - | |
17 | Phosphorylation | GIDLGTTYSCVGVFQ EEECCCCEEEEEEEE | 10.42 | - | |
18 | Phosphorylation | IDLGTTYSCVGVFQH EECCCCEEEEEEEEC | 10.55 | 29759185 | |
27 | Ubiquitination | VGVFQHGKVEIIAND EEEEECCEEEEEECC | 34.27 | - | |
39 | Phosphorylation | ANDQGNRTTPSYVAF ECCCCCCCCCCEEEE | 47.24 | 21945579 | |
40 | Phosphorylation | NDQGNRTTPSYVAFT CCCCCCCCCCEEEEE | 13.65 | 21945579 | |
42 | Phosphorylation | QGNRTTPSYVAFTDT CCCCCCCCEEEEECH | 30.10 | 21945579 | |
42 | O-linked_Glycosylation | QGNRTTPSYVAFTDT CCCCCCCCEEEEECH | 30.10 | 28657654 | |
43 | Phosphorylation | GNRTTPSYVAFTDTE CCCCCCCEEEEECHH | 9.30 | 21945579 | |
47 | Phosphorylation | TPSYVAFTDTERLIG CCCEEEEECHHHHHH | 32.07 | 21945579 | |
49 | Phosphorylation | SYVAFTDTERLIGDA CEEEEECHHHHHHHH | 21.68 | 21945579 | |
51 | Methylation | VAFTDTERLIGDAAK EEEECHHHHHHHHHH | 33.43 | - | |
58 | Ubiquitination | RLIGDAAKNQVAMNP HHHHHHHHCCCCCCC | 50.02 | - | |
68 | Phosphorylation | VAMNPQNTVFDAKRL CCCCCCCCHHHHHHH | 19.80 | 20068231 | |
73 | Methylation | QNTVFDAKRLIGRKF CCCHHHHHHHHCCCC | 49.97 | 19864871 | |
73 | Ubiquitination | QNTVFDAKRLIGRKF CCCHHHHHHHHCCCC | 49.97 | - | |
117 | Phosphorylation | KGENKAFYPEEISSM CCCCCCCCHHHHHHH | 18.00 | 20068231 | |
122 | Phosphorylation | AFYPEEISSMVLTKL CCCHHHHHHHHHHHH | 18.70 | 20068231 | |
123 | Phosphorylation | FYPEEISSMVLTKLK CCHHHHHHHHHHHHH | 20.69 | 20068231 | |
127 | Phosphorylation | EISSMVLTKLKETAE HHHHHHHHHHHHHHH | 23.95 | 20068231 | |
132 | Phosphorylation | VLTKLKETAEAFLGH HHHHHHHHHHHHHCC | 28.36 | 20068231 | |
142 | Phosphorylation | AFLGHPVTNAVITVP HHHCCCCCCEEEEEE | 23.16 | 20068231 | |
147 | Phosphorylation | PVTNAVITVPAYFND CCCCEEEEEECCCCH | 17.53 | 28152594 | |
151 | Phosphorylation | AVITVPAYFNDSQRQ EEEEEECCCCHHHCC | 9.24 | 28152594 | |
155 | Phosphorylation | VPAYFNDSQRQATKD EECCCCHHHCCHHHC | 28.50 | 17525332 | |
160 | Phosphorylation | NDSQRQATKDAGVIA CHHHCCHHHCCCCCC | 22.56 | - | |
161 | Ubiquitination | DSQRQATKDAGVIAG HHHCCHHHCCCCCCC | 48.90 | 21906983 | |
179 | Phosphorylation | LRIINEPTAAAIAYG HHHCCCCCHHHHHHC | 23.81 | 28152594 | |
185 | Phosphorylation | PTAAAIAYGLDKGGQ CCHHHHHHCCCCCCC | 16.47 | 28152594 | |
189 | Methylation | AIAYGLDKGGQGERH HHHHCCCCCCCCCCE | 70.73 | - | |
222 | Ubiquitination | DDGIFEVKATAGDTH CCCEEEEEEEECCCC | 32.59 | - | |
224 | Phosphorylation | GIFEVKATAGDTHLG CEEEEEEEECCCCCC | 26.00 | 29396449 | |
241 | Phosphorylation | DFDNRLVSHFVEEFK CCHHHHHHHHHHHHH | 18.79 | - | |
248 | Acetylation | SHFVEEFKRKHKKDI HHHHHHHHHHHHHCH | 64.91 | 25038526 | |
252 | Ubiquitination | EEFKRKHKKDISQNK HHHHHHHHHCHHHHH | 56.00 | - | |
253 | Ubiquitination | EFKRKHKKDISQNKR HHHHHHHHCHHHHHH | 61.07 | - | |
256 | Phosphorylation | RKHKKDISQNKRAVR HHHHHCHHHHHHHHH | 37.52 | 20068231 | |
259 | Ubiquitination | KKDISQNKRAVRRLR HHCHHHHHHHHHHHH | 33.81 | 21890473 | |
267 | Phosphorylation | RAVRRLRTACERAKR HHHHHHHHHHHHHHH | 40.01 | 27273156 | |
275 | Phosphorylation | ACERAKRTLSSSTQA HHHHHHHHHCCCHHH | 30.22 | - | |
298 | Phosphorylation | EGIDFYTSITRARFE CCCCHHHHHHHHHHH | 15.58 | 20860994 | |
300 | Phosphorylation | IDFYTSITRARFEEL CCHHHHHHHHHHHHH | 20.31 | 20860994 | |
321 | Acetylation | GTLEPVEKALRDAKM CCCHHHHHHHHHCCC | 53.61 | 19608861 | |
330 | Ubiquitination | LRDAKMDKAKIHDIV HHHCCCCHHCCCEEE | 48.34 | - | |
332 | Acetylation | DAKMDKAKIHDIVLV HCCCCHHCCCEEEEE | 46.44 | 25038526 | |
332 | Ubiquitination | DAKMDKAKIHDIVLV HCCCCHHCCCEEEEE | 46.44 | - | |
363 | Ubiquitination | FNGRDLNKSINPDEA HCCCCCCCCCCHHHH | 61.07 | 21906983 | |
364 | Phosphorylation | NGRDLNKSINPDEAV CCCCCCCCCCHHHHH | 26.90 | 30278072 | |
373 | Phosphorylation | NPDEAVAYGAAVQAA CHHHHHHHHHHHHHH | 10.74 | 18669648 | |
387 | Phosphorylation | AILMGDKSEKVQDLL HHHCCCCCHHHHHHH | 47.60 | - | |
402 | Phosphorylation | LLDVAPLSLGLETAG HHCHHCCCCCCCCCH | 21.23 | - | |
413 | Phosphorylation | ETAGGVMTALIKRNS CCCHHHHHHHHHCCC | 18.86 | - | |
417 | Ubiquitination | GVMTALIKRNSTIPT HHHHHHHHCCCCCCC | 46.51 | - | |
418 | Methylation | VMTALIKRNSTIPTK HHHHHHHCCCCCCCC | 35.02 | - | |
420 | Phosphorylation | TALIKRNSTIPTKQT HHHHHCCCCCCCCCE | 31.57 | 30266825 | |
421 | Phosphorylation | ALIKRNSTIPTKQTQ HHHHCCCCCCCCCEE | 34.23 | 30266825 | |
424 | Phosphorylation | KRNSTIPTKQTQIFT HCCCCCCCCCEEEEE | 31.75 | 28102081 | |
425 | Ubiquitination | RNSTIPTKQTQIFTT CCCCCCCCCEEEEEE | 46.09 | 21906983 | |
431 | Phosphorylation | TKQTQIFTTYSDNQP CCCEEEEEEECCCCC | 26.84 | 28152594 | |
432 | Phosphorylation | KQTQIFTTYSDNQPG CCEEEEEEECCCCCE | 15.41 | 28152594 | |
433 | Phosphorylation | QTQIFTTYSDNQPGV CEEEEEEECCCCCEE | 15.80 | 28152594 | |
434 | Phosphorylation | TQIFTTYSDNQPGVL EEEEEEECCCCCEEE | 28.17 | 28152594 | |
445 | Phosphorylation | PGVLIQVYEGERAMT CEEEEEEEECCCCCC | 11.22 | 20068231 | |
453 | Ubiquitination | EGERAMTKDNNLLGR ECCCCCCCCCCCCCC | 45.43 | 21906983 | |
464 | Phosphorylation | LLGRFDLTGIPPAPR CCCCCCCCCCCCCCC | 34.60 | 21406692 | |
471 | Methylation | TGIPPAPRGVPQIEV CCCCCCCCCCCEEEE | 61.93 | - | |
479 | Phosphorylation | GVPQIEVTFDIDANG CCCEEEEEEEECCCC | 11.64 | 22817900 | |
502 | Ubiquitination | KSTGKVNKITITNDK CCCCCEEEEEEECCC | 44.19 | - | |
504 | Phosphorylation | TGKVNKITITNDKGR CCCEEEEEEECCCCC | 24.29 | 22817900 | |
509 | Acetylation | KITITNDKGRLSKEE EEEEECCCCCCCHHH | 48.26 | 72617493 | |
509 | Sumoylation | KITITNDKGRLSKEE EEEEECCCCCCCHHH | 48.26 | - | |
509 | Ubiquitination | KITITNDKGRLSKEE EEEEECCCCCCCHHH | 48.26 | 21906983 | |
509 | Sumoylation | KITITNDKGRLSKEE EEEEECCCCCCCHHH | 48.26 | - | |
513 | Phosphorylation | TNDKGRLSKEEIERM ECCCCCCCHHHHHHH | 36.34 | 20873877 | |
514 | Ubiquitination | NDKGRLSKEEIERMV CCCCCCCHHHHHHHH | 65.05 | 21906983 | |
514 | Acetylation | NDKGRLSKEEIERMV CCCCCCCHHHHHHHH | 65.05 | 72589429 | |
527 | Phosphorylation | MVLDAEKYKAEDEVQ HHHCHHHHCCHHHHH | 13.61 | 30257219 | |
528 | Ubiquitination | VLDAEKYKAEDEVQR HHCHHHHCCHHHHHH | 57.26 | 21906983 | |
528 | Acetylation | VLDAEKYKAEDEVQR HHCHHHHCCHHHHHH | 57.26 | 25038526 | |
541 | Ubiquitination | QREKIAAKNALESYA HHHHHHHHHHHHHHC | 33.46 | - | |
546 | Phosphorylation | AAKNALESYAFNMKS HHHHHHHHHCCCCHH | 23.70 | 28152594 | |
547 | Phosphorylation | AKNALESYAFNMKSV HHHHHHHHCCCCHHC | 13.06 | 28152594 | |
556 | Phosphorylation | FNMKSVVSDEGLKGK CCCHHCCCCCCCCCC | 27.99 | 30622161 | |
599 | Acetylation | DEFDHKRKELEQMCN CCHHHHHHHHHHHHH | 72.03 | 25038526 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HS71L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HS71L_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...